1. Szelenberger W, Jakitowicz J. Bezsenność – problem diagnostyczny i terapeutyczny. In: Szelenberger W, Nowicki Z, eds. Zaburzenia snu. Diagnostyka i leczenie, wybrane zagadnienia. Kraków: Komitet Redakcyjno-Wydawniczy Polskiego Towarzystwa Psychiatrycznego; 1999: 19–31 (in Polish).
2.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington: American Psychiatric Association; 2013.
3.
Stavropoulos K, Imprialos KP, Doumas M, et al. Insomnia and hypertension: a misty landscape. J Clin Hypertens (Greenwich) 2019; 21(6): 835–837, doi: 10.1111/jch.13519.
4.
Liu RQ, Qian Z, Trevathan E, et al. Poor sleep quality associated with high risk of hypertension and elevated blood pressure in China: results from a large population-based study. Hypertens Res 2016; 39(1): 54–59.
5.
Vgontzas AN, Liao D, Bixler EO, et al. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009; 32(4): 491–497.
6.
Lemmer B, Oster H. The role of circadian rhythms in the hypertension of diabetes mellitus and the metabolic syndrome. Curr Hypertens Rep 2018; 20: 43, doi: 10.1007/s11906-018-0843-5.
7.
Pallayova M, Donic V, Gresova S, et al. Do differences in sleep architecture exist between persons with type 2 diabetes and nondiabetic controls? J Diabetes Sci Technol 2010; 4: 344–352.
8.
Tsujimura T, Matsuo Y, Keyaki T, et al. Correlations of sleep disturbance with the immune system in type 2 diabetes mellitus. Diabetes Res Clin Pract 2009; 85: 286–292.
9.
Xia L, Chen GH, Li ZH, et al. Alterations in hypothalamus-pituitary-adrenal/thyroid axes and gonadotropin-releasing hormone in the patients with primary insomnia: a clinical research. PLoS One 2013; 8(8): e71065, doi: 10.1371/journal.pone.0071065.
10.
Ikegami K, Refetoff S, Van Cauter E, et al. Interconnection between circadian clocks and thyroid function. Nat Rev Endocrinol 2019; 15(10): 590–600.
11.
Masek K, Slánský J, Petrovický P, et al. Neuroendocrine immune interactions in health and disease. Int Immunopharmacol 2003; 3(8): 1235–1246.
12.
Vancampfort D, Stubbs B, Firth J, et al. Sedentary behaviour and sleep problems among 42,489 community-dwelling adults in six low- and middle-income countries. J Sleep Res 2018: e12714, doi: 10.1111/jsr.12714.
13.
Vallières A, Azaiez A, Moreau V, et al. Insomnia in shift work. Sleep Med 2014; 15(12): 1440–1448.
14.
Pepin E, Gillet P, Sauvet F, et al. Shift work, night work and sleep disorders among pastry cookers and shopkeepers in France: a cross-sectional survey. BMJ Open 2018; 8(5), doi: 10.1136/bmjopen-2017-019098.
15.
Żołnierczyk-Zreda D. Rodzaj umowy o pracę a zdrowie i funkcjonowanie zawodowe pracowników – przegląd badań. Med Pr 2015; 66(4): 565–573 (in Polish).
16.
Hein M, Lanquart JP, Loas G, et al. Prevalence and risk factors of type 2 diabetes in insomnia sufferers: a study on 1311 individuals referred for sleep examinations. Sleep Med 2018; 46: 37–45.
17.
Błaszczyk R, Wysokiński A, Ciota M, et al. Zaburzenia snu oraz senność dzienna u pacjentów z nadciśnieniem tętniczym. Pol Przegl Kardiol 2010; 12(2): 109–115 (in Polish).
18.
Wolińska W, Pawlak IE, Mroczek B. Coexistence of insomnia and chronic diseases in over 60 years old. Fam Med Primary Care Rev 2016; 18(3): 364–367.
19.
Sundbom F, Lindberg E, Bjerg A, et al. Asthma symptoms and nasal congestion as independent risk factors for insomnia in a general population: results from the GA(2)LEN survey. Allergy 2013; 68(2): 213–219.
20.
Caputo M, Pecere A, Sarro A, et al. Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy. Endocrine 2020, doi: 10.1007/s12020-020-02222-7.
